Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRM125 for Ambulatory Blood Pressure in Hypertension
NCT05195827Phase 3Withdrawn
- Sponsor
- PRM Pharma, LLC
- Start
- Dec 2021
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of chlorthalidone in hypertension (HTN), sponsored by PRM Pharma, LLC. Planned start Dec 2021; status: withdrawn.
02
Drugs
chlorthalidone
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT05195827.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05195827.